Mengting Liao

1.2k total citations · 1 hit paper
31 papers, 883 citations indexed

About

Mengting Liao is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Mengting Liao has authored 31 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Mengting Liao's work include Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Mengting Liao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Mengting Liao collaborates with scholars based in China, United States and Canada. Mengting Liao's co-authors include Huabin Hu, Tullia C. Bruno, Deepali V. Sawant, Jin Huang, Arjun Pennathur, David B. Corry, Creg J. Workman, Hiroshi Yano, Amanda C. Poholek and Maria Chikina and has published in prestigious journals such as Journal of Clinical Oncology, Nature Immunology and PLoS ONE.

In The Last Decade

Mengting Liao

29 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion

2019 388 citations Deepali V. Sawant, Hiroshi Yano et al. Nature Immunology profile →

Peers

Countries citing papers authored by Mengting Liao

Since Specialization

Citations

This map shows the geographic impact of Mengting Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengting Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengting Liao more than expected).

Fields of papers citing papers by Mengting Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengting Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengting Liao. The network helps show where Mengting Liao may publish in the future.

Co-authorship network of co-authors of Mengting Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Mengting Liao. A scholar is included among the top collaborators of Mengting Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengting Liao. Mengting Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CHI3L1: a key driver in gastritis-to-cancer transformation 2025 ·Journal of Translational Medicine ·Tao Li, (unknown), Yihong Gong, Mengting Liao, (unknown), (unknown), (unknown), Yinan Yan, (unknown), Runhua Chen, Yuan Li, Yan Chen, Jie Lin, Yicong Li, Xia Ding	1
2	Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validation 2024 ·Journal of Ethnopharmacology ·Yan Chen, (unknown), Haocheng Zheng, (unknown), (unknown), (unknown), Jie Lin, Tao Li, Mengting Liao, Yuhang Li, Shuzhen Guo, Xia Ding	3
3	The Clinical Characteristic and Management of Patients with Nocardiosis in a Tertiary Hospital in China 2023 ·Journal of Microbiology and Biotechnology ·Peilin Liu, Zhiqian Wang, Zijuan Jian, Xuan Liu, Yanming Li, (unknown), (unknown), Mengting Liao, Xianghui Liang, Wenen Liu	0
4	Pharmacodynamics and pharmacological mechanism of Moluodan concentrated pill in the treatment of atrophic gastritis: A network pharmacological study and in vivo experiments 2023 ·Journal of Ethnopharmacology ·(unknown), (unknown), Zeqi Su, Fuhao Chu, Yuan Li, Yan Chen, Mengting Liao, Ping Li, (unknown), Xiangmei Meng, Ping Zhang, Xia Ding	13
5	Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1 2023 ·Theranostics ·Rui Hu, (unknown), Yao Li, Minghui Zhang, Xin Li, Yanzhong Chen, (unknown), Hongyin Sun, (unknown), Mengting Liao, Dongsheng Cao, Qin Yan, Xiang Chen, Mingzhu Yin	11
6	Consumption of Red Meat and Atopic Dermatitis: A Cross-Sectional Study in Chinese College Students 2022 ·Dermatitis ·Mengting Liao, Juan Su, Ji Li, Juan Tao, Xiaojing Kang, Bin Wu, Shijun Shan, Xiaohui Wang, Xiang Chen, Yi Xiao, Minxue Shen	0
7	BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway 2022 ·Pharmacological Research ·Rui Hu, Yao Li, Ying Guo, Xin Li, (unknown), Mengting Liao, (unknown), Hongyin Sun, Shuang Zhao, Juan Su, Xiang Chen, Mingzhu Yin	11
8	First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis 2021 ·Cost Effectiveness and Resource Allocation ·Youwen Zhu, Huabin Hu, Dong Ding, (unknown), Mengting Liao, Yin Shi, Jin Huang	19
9	Distinguishing Hepatocellular Carcinoma From Hepatic Inflammatory Pseudotumor Using a Nomogram Based on Contrast-Enhanced Ultrasound 2021 ·Frontiers in Oncology ·Mengting Liao, (unknown), Bo Zhang, Qin Jiang, Juan Liu, (unknown)	6
10	The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies 2021 ·Journal of Ethnopharmacology ·Yan Chen, Fuhao Chu, Jie Lin, Zeqi Su, Mengting Liao, Tao Li, Yuan Li, Nadia Johnson, Haocheng Zheng, Xia Ding	15
11	Development and clinical application of a rapid SARS‐CoV‐2 antibody test strip: A multi‐center assessment across China 2020 ·Journal of Clinical Laboratory Analysis ·Mengting Liao, Jiawei Yan, Xin‐Feng Wang, Huimin Qian, (unknown), Dan Xu, Bin Wang, Bo Yang, (unknown), (unknown), Qian Gao, Qian Zhou, (unknown), Zongxiang Li, Wenen Liu	8
12	Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma 2020 ·Frontiers in Oncology ·Furong Zeng, Juan Su, Cong Peng, Mengting Liao, Shuang Zhao, Ying Guo, Xiang Chen, Guangtong Deng	15
13	Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer 2020 ·Frontiers in Oncology ·Huabin Hu, (unknown), Mengting Liao, Yin Shi, Linli Yao, Dong Ding, Youwen Zhu, Shan Zeng, David P. Carbone, Jin Huang	33
14	Laparoscopic versus open gastrectomy for gastric cancer 2020 ·World Journal of Surgical Oncology ·Furong Zeng, Lang Chen, Mengting Liao, Bin Chen, Jing Long, Wei Wu, Guangtong Deng	36
15	Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer 2020 ·Advances in Therapy ·Dong Ding, Huabin Hu, Mengting Liao, Yin Shi, (unknown), Linli Yao, Youwen Zhu, Shan Zeng, Jin Huang	23
16	Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater 2019 ·Lung Cancer ·(unknown), Huabin Hu, Mengting Liao, Xuefeng Xia, Yin Shi, Linli Yao, Dong Ding, Youwen Zhu, Shan Zeng, Liangfang Shen, Jin Huang, David P. Carbone	47
17	Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion breakdown → 2019 ·Nature Immunology ·Deepali V. Sawant, Hiroshi Yano, Maria Chikina, Qianxia Zhang, Mengting Liao, Chang Liu, Derrick Callahan, Zhe Sun, Tao Sun, Tracy Tabib, Arjun Pennathur, David B. Corry, James D. Luketich, Robert Lafyatis, Wei Chen, Amanda C. Poholek, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali	388
18	Efficacy and safety of acupuncture therapy for chronic atrophic gastritis 2019 ·Medicine ·Yuan Li, Yili Zhang, Meng Han, Mengting Liao, Zeqi Su, (unknown), Lingling Jiang, Ping Li, Xia Ding	11
19	The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis 2017 ·PLoS ONE ·Hui Li, (unknown), (unknown), (unknown), Mengting Liao, Jing Wang, Yanwen Li, Zihao Xu	20
20	MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4 2016 ·Scientific Reports ·Hui Li, Ruoyun Ouyang, Zi Wang, Weihua Zhou, Huiyong Chen, Yawen Jiang, Yibin Zhang, Mengting Liao, Weiwei Wang, Mao Ye, (unknown), Xueping Feng, Jing Liu, Bin Zhang	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact